Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Luddy

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMJ Oncology|July 7, 2025
Extending the functional lifespan of natural killer (NK) cells: towards durable cytotoxicity in NK-cell based immunotherapyKimberly Luddy, Hannah Newman
PET Clinics|October 24, 2025
Radiopharmaceutical Therapy and Immunotherapy Combinations Utilizing Cancer Evolution and Computational Modeling in Metastatic Prostate CancerKimberly Luddy, Hannah Newman, Jordan Gravon, et al.
Cancer Biology & Therapy|August 7, 2013
Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growthMelanie Mediavilla-Varela, Kimberly Luddy, David Noyes, et al.
Breast Cancer Research : BCR|July 2, 2017
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survivalJan Poleszczuk, Kimberly Luddy, Lu Chen, et al.
Plos One|December 16, 2014
Transforming growth factor β signaling overcomes dasatinib resistance in lung cancerEdna Gordian, Jiannong Li, Yuri Pevzner, et al.
JCO Clinical Cancer Informatics|February 12, 2019
The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game TheoryJeffrey West, Mark Robertson-Tessi, Kimberly Luddy, et al.
Cancer Research|January 1, 2016
Neutralization of Tumor Acidity Improves Antitumor Responses to ImmunotherapyShari Pilon-Thomas, Krithika N Kodumudi, Asmaa E El-Kenawi, et al.
Cancers|January 8, 2023
Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer SubtypesAudrey R Freischel, Jamie K Teer, Kimberly Luddy, et al.
British Journal of Cancer|October 7, 2020
Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms raceArig Ibrahim-Hashim, Kimberly Luddy, Dominique Abrahams, et al.
British Journal of Cancer|August 17, 2019
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancerAsmaa El-Kenawi, Chandler Gatenbee, Mark Robertson-Tessi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMJ Oncology|July 7, 2025
Extending the functional lifespan of natural killer (NK) cells: towards durable cytotoxicity in NK-cell based immunotherapyKimberly Luddy, Hannah Newman
PET Clinics|October 24, 2025
Radiopharmaceutical Therapy and Immunotherapy Combinations Utilizing Cancer Evolution and Computational Modeling in Metastatic Prostate CancerKimberly Luddy, Hannah Newman, Jordan Gravon, et al.
Cancer Biology & Therapy|August 7, 2013
Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growthMelanie Mediavilla-Varela, Kimberly Luddy, David Noyes, et al.
Breast Cancer Research : BCR|July 2, 2017
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survivalJan Poleszczuk, Kimberly Luddy, Lu Chen, et al.
Plos One|December 16, 2014
Transforming growth factor β signaling overcomes dasatinib resistance in lung cancerEdna Gordian, Jiannong Li, Yuri Pevzner, et al.
JCO Clinical Cancer Informatics|February 12, 2019
The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game TheoryJeffrey West, Mark Robertson-Tessi, Kimberly Luddy, et al.
Cancer Research|January 1, 2016
Neutralization of Tumor Acidity Improves Antitumor Responses to ImmunotherapyShari Pilon-Thomas, Krithika N Kodumudi, Asmaa E El-Kenawi, et al.
Cancers|January 8, 2023
Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer SubtypesAudrey R Freischel, Jamie K Teer, Kimberly Luddy, et al.
British Journal of Cancer|October 7, 2020
Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms raceArig Ibrahim-Hashim, Kimberly Luddy, Dominique Abrahams, et al.
British Journal of Cancer|August 17, 2019
Acidity promotes tumour progression by altering macrophage phenotype in prostate cancerAsmaa El-Kenawi, Chandler Gatenbee, Mark Robertson-Tessi, et al.
Pageof 2